Detalles de la búsqueda
1.
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy.
Target Oncol
; 11(3): 383-400, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26706237
2.
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.
Eur J Cancer
; 51(1): 18-26, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25466509
Resultados
1 -
2
de 2
1
Próxima >
>>